ID   PI3R4_HUMAN             Reviewed;        1358 AA.
AC   Q99570; Q2TBF4;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Phosphoinositide 3-kinase regulatory subunit 4;
DE            Short=PI3-kinase regulatory subunit 4;
DE            EC=2.7.11.1;
DE   AltName: Full=PI3-kinase p150 subunit;
DE   AltName: Full=Phosphoinositide 3-kinase adaptor protein;
GN   Name=PIK3R4; Synonyms=VPS15 {ECO:0000303|PubMed:23878393};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 53-63; 333-343;
RP   540-554 AND 786-791, MYRISTOYLATION AT GLY-2, PHOSPHORYLATION,
RP   COFACTOR, TISSUE SPECIFICITY, AND INTERACTION WITH PIK3C3.
RX   PubMed=8999962; DOI=10.1074/jbc.272.4.2477;
RA   Panaretou C., Domin J., Cockcroft S., Waterfield M.D.;
RT   "Characterization of p150, an adaptor protein for the human
RT   phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by
RT   phosphatidylinositol transfer protein to the p150.PtdIns 3-kinase
RT   complex.";
RL   J. Biol. Chem. 272:2477-2485(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH RAB7A AND PIK3C3/VPS34, AND SUBCELLULAR LOCATION.
RX   PubMed=14617358; DOI=10.1034/j.1600-0854.2003.00133.x;
RA   Stein M.P., Feng Y., Cooper K.L., Welford A.M., Wandinger-Ness A.;
RT   "Human VPS34 and p150 are Rab7 interacting partners.";
RL   Traffic 4:754-771(2003).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1316, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-808; SER-853 AND
RP   SER-865, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=20643123; DOI=10.1016/j.yexcr.2010.07.008;
RA   Thoresen S.B., Pedersen N.M., Liestol K., Stenmark H.;
RT   "A phosphatidylinositol 3-kinase class III sub-complex containing
RT   VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and
RT   degradative endocytic traffic.";
RL   Exp. Cell Res. 316:3368-3378(2010).
RN   [8]
RP   INTERACTION WITH BECN1; RUBCN; ATG14; PIK3C3 AND UVRAG.
RX   PubMed=19270696; DOI=10.1038/ncb1846;
RA   Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N.,
RA   Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S.,
RA   Noda T., Yoshimori T.;
RT   "Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally
RT   regulate autophagy at different stages.";
RL   Nat. Cell Biol. 11:385-396(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-813, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   INTERACTION WITH BECN1.
RX   PubMed=23878393; DOI=10.1128/MCB.00079-13;
RA   Fogel A.I., Dlouhy B.J., Wang C., Ryu S.W., Neutzner A., Hasson S.A.,
RA   Sideris D.P., Abeliovich H., Youle R.J.;
RT   "Role of membrane association and Atg14-dependent phosphorylation in
RT   beclin-1-mediated autophagy.";
RL   Mol. Cell. Biol. 33:3675-3688(2013).
RN   [13]
RP   INTERACTION WITH NRBF2.
RX   PubMed=24785657; DOI=10.1042/BJ20140515;
RA   Cao Y., Wang Y., Abi Saab W.F., Yang F., Pessin J.E., Backer J.M.;
RT   "NRBF2 regulates macroautophagy as a component of Vps34 Complex I.";
RL   Biochem. J. 461:315-322(2014).
RN   [14]
RP   RECONSTITUTION OF THE PI3K COMPLEX I, AND ELECTRON MICROSCOPY OF THE
RP   PI3K COMPLEX I.
RX   PubMed=25490155; DOI=10.7554/eLife.05115;
RA   Baskaran S., Carlson L.A., Stjepanovic G., Young L.N., Kim do J.,
RA   Grob P., Stanley R.E., Nogales E., Hurley J.H.;
RT   "Architecture and dynamics of the autophagic phosphatidylinositol 3-
RT   kinase complex.";
RL   Elife 3:0-0(2014).
RN   [15]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U.,
RA   Wright M.H., Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated
RT   proteomes in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-936.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-273; HIS-342; TRP-347; ILE-388;
RP   ASN-393; VAL-699 AND VAL-1043.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Regulatory subunit of the PI3K complex that mediates
CC       formation of phosphatidylinositol 3-phosphate; different complex
CC       forms are believed to play a role in multiple membrane trafficking
CC       pathways: PI3KC3-C1 is involved in initiation of autophagosomes
CC       and PI3KC3-C2 in maturation of autophagosomes and endocytosis.
CC       Involved in regulation of degradative endocytic trafficking and
CC       cytokinesis, probably in the context of PI3KC3-C2
CC       (PubMed:20643123). {ECO:0000269|PubMed:20643123}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:8999962};
CC   -!- SUBUNIT: Component of the PI3K (PI3KC3/PI3K-III/class III
CC       phosphatidylinositol 3-kinase) complex the core of which is
CC       composed of the catalytic subunit PIK3C3, the regulatory subunit
CC       PIK3R4 and BECN1 associating with additional regulatory/auxilliary
CC       subunits to form alternative complex forms. Alternative complex
CC       forms containing a forth regulatory subunit in a mutually
CC       exclusive manner are PI3K complex I (PI3KC3-C1) containing ATG14,
CC       and PI3K complex II (PI3KC3-C2) containing UVRAG (PubMed:8999962,
CC       PubMed:19270696, PubMed:23878393, PubMed:25490155). PI3KC3-C1
CC       displays a V-shaped architecture with PIK3R4 serving as a bridge
CC       between PIK3C3 and the ATG14:BECN1 subcomplex (PubMed:25490155).
CC       Both, PI3KC3-C1 and PI3KC3-C2, can associate with further
CC       regulatory subunits, such as RUBCN, SH3GLB1/Bif-1, AMBRA1 and
CC       NRBF2 (PubMed:19270696, PubMed:20643123, PubMed:24785657). PI3KC3-
CC       C1 probably associates with PIK3CB (By similarity). Interacts with
CC       RAB7A in the presence of PIK3C3/VPS34 (PubMed:14617358). Interacts
CC       with NRBF2 (PubMed:24785657). {ECO:0000250|UniProtKB:Q8VD65,
CC       ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:19270696,
CC       ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:23878393,
CC       ECO:0000269|PubMed:24785657, ECO:0000269|PubMed:25490155,
CC       ECO:0000269|PubMed:8999962}.
CC   -!- INTERACTION:
CC       Q96F24:NRBF2; NbExp=10; IntAct=EBI-1046979, EBI-2362014;
CC   -!- SUBCELLULAR LOCATION: Late endosome {ECO:0000269|PubMed:14617358}.
CC       Cytoplasmic vesicle, autophagosome {ECO:0000305}. Membrane
CC       {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=As component of
CC       the PI3K complex I localized to pre-autophagosome structures. As
CC       component of the PI3K complex II localized predominantly to
CC       endosomes. Localizes also to discrete punctae along the ciliary
CC       axoneme (By similarity). {ECO:0000250|UniProtKB:Q8VD65,
CC       ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:8999962}.
CC   -!- PTM: Myristoylated. {ECO:0000269|PubMed:8999962}.
CC   -!- PTM: Probably autophosphorylated. {ECO:0000269|PubMed:8999962}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y08991; CAA70176.1; -; mRNA.
DR   EMBL; BC110318; AAI10319.1; -; mRNA.
DR   EMBL; BC127106; AAI27107.1; -; mRNA.
DR   CCDS; CCDS3067.1; -.
DR   RefSeq; NP_055417.1; NM_014602.2.
DR   UniGene; Hs.149032; -.
DR   ProteinModelPortal; Q99570; -.
DR   BioGrid; 119059; 23.
DR   DIP; DIP-42310N; -.
DR   IntAct; Q99570; 19.
DR   MINT; MINT-1631706; -.
DR   STRING; 9606.ENSP00000349205; -.
DR   BindingDB; Q99570; -.
DR   ChEMBL; CHEMBL2189144; -.
DR   iPTMnet; Q99570; -.
DR   PhosphoSitePlus; Q99570; -.
DR   BioMuta; PIK3R4; -.
DR   DMDM; 74762700; -.
DR   EPD; Q99570; -.
DR   MaxQB; Q99570; -.
DR   PaxDb; Q99570; -.
DR   PeptideAtlas; Q99570; -.
DR   PRIDE; Q99570; -.
DR   DNASU; 30849; -.
DR   Ensembl; ENST00000356763; ENSP00000349205; ENSG00000196455.
DR   GeneID; 30849; -.
DR   KEGG; hsa:30849; -.
DR   UCSC; uc003enj.4; human.
DR   CTD; 30849; -.
DR   DisGeNET; 30849; -.
DR   GeneCards; PIK3R4; -.
DR   HGNC; HGNC:8982; PIK3R4.
DR   HPA; HPA036032; -.
DR   HPA; HPA036033; -.
DR   MIM; 602610; gene.
DR   neXtProt; NX_Q99570; -.
DR   OpenTargets; ENSG00000196455; -.
DR   PharmGKB; PA33315; -.
DR   eggNOG; KOG1240; Eukaryota.
DR   eggNOG; ENOG410XPDN; LUCA.
DR   GeneTree; ENSGT00390000016225; -.
DR   HOGENOM; HOG000216566; -.
DR   HOVERGEN; HBG079542; -.
DR   InParanoid; Q99570; -.
DR   KO; K08333; -.
DR   OMA; QWLGRLR; -.
DR   OrthoDB; EOG091G00QT; -.
DR   PhylomeDB; Q99570; -.
DR   TreeFam; TF102034; -.
DR   BioCyc; MetaCyc:HS03788-MONOMER; -.
DR   Reactome; R-HSA-109704; PI3K Cascade.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1660517; Synthesis of PIPs at the late endosome membrane.
DR   Reactome; R-HSA-168138; Toll Like Receptor 9 (TLR9) Cascade.
DR   Reactome; R-HSA-5668599; RHO GTPases Activate NADPH Oxidases.
DR   SignaLink; Q99570; -.
DR   SIGNOR; Q99570; -.
DR   ChiTaRS; PIK3R4; human.
DR   GeneWiki; PIK3R4; -.
DR   GenomeRNAi; 30849; -.
DR   PRO; PR:Q99570; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000196455; -.
DR   CleanEx; HS_PIK3R4; -.
DR   ExpressionAtlas; Q99570; baseline and differential.
DR   Genevisible; Q99570; HS.
DR   GO; GO:0005776; C:autophagosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005930; C:axoneme; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005643; C:nuclear pore; IBA:GO_Central.
DR   GO; GO:0071561; C:nucleus-vacuole junction; IBA:GO_Central.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; ISS:UniProtKB.
DR   GO; GO:0034271; C:phosphatidylinositol 3-kinase complex, class III, type I; IBA:GO_Central.
DR   GO; GO:0034272; C:phosphatidylinositol 3-kinase complex, class III, type II; IBA:GO_Central.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; NAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0045324; P:late endosome to vacuole transport; IBA:GO_Central.
DR   GO; GO:0016236; P:macroautophagy; IBA:GO_Central.
DR   GO; GO:0030242; P:pexophagy; IBA:GO_Central.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0006623; P:protein targeting to vacuole; IBA:GO_Central.
DR   GO; GO:0032801; P:receptor catabolic process; IMP:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00400; WD40; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF50978; SSF50978; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50077; HEAT_REPEAT; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Endosome; Kinase; Lipoprotein; Membrane;
KW   Myristate; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase;
KW   Transferase; WD repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:25255805}.
FT   CHAIN         2   1358       Phosphoinositide 3-kinase regulatory
FT                                subunit 4.
FT                                /FTId=PRO_0000086524.
FT   DOMAIN       26    324       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REPEAT      413    450       HEAT 1.
FT   REPEAT      458    495       HEAT 2.
FT   REPEAT      572    610       HEAT 3.
FT   REPEAT      991   1030       WD 1.
FT   REPEAT     1040   1079       WD 2.
FT   REPEAT     1093   1134       WD 3.
FT   REPEAT     1139   1178       WD 4.
FT   REPEAT     1182   1223       WD 5.
FT   REPEAT     1237   1278       WD 6.
FT   REPEAT     1327   1358       WD 7.
FT   NP_BIND      32     40       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    781    784       Poly-Glu.
FT   COMPBIAS    974    977       Poly-Pro.
FT   ACT_SITE    148    148       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      53     53       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     808    808       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     813    813       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     853    853       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     865    865       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES    1316   1316       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:25255805,
FT                                ECO:0000269|PubMed:8999962}.
FT   VARIANT     273    273       F -> L (in dbSNP:rs55951445).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040997.
FT   VARIANT     342    342       R -> H (in dbSNP:rs56295394).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040998.
FT   VARIANT     347    347       R -> W (in dbSNP:rs34797184).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040999.
FT   VARIANT     388    388       T -> I (in dbSNP:rs34663155).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041000.
FT   VARIANT     393    393       D -> N (in dbSNP:rs34633532).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041001.
FT   VARIANT     699    699       L -> V (in dbSNP:rs56369596).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041002.
FT   VARIANT     936    936       R -> Q (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs181132426).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035632.
FT   VARIANT    1043   1043       G -> V (in dbSNP:rs56160735).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041003.
FT   CONFLICT    342    343       RI -> EK (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    553    554       KQ -> FK (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1358 AA;  153103 MW;  5B402175265B21F7 CRC64;
     MGNQLAGIAP SQILSVESYF SDIHDFEYDK SLGSTRFFKV ARAKHREGLV VVKVFAIQDP
     TLPLTSYKQE LEELKIRLNS AQNCLPFQKA SEKASEKAAM LFRQYVRDNL YDRISTRPFL
     NNIEKRWIAF QILTAVDQAH KSGVRHGDIK TENVMVTSWN WVLLTDFASF KPTYLPEDNP
     ADFNYFFDTS RRRTCYIAPE RFVDGGMFAT ELEYMRDPST PLVDLNSNQR TRGELKRAMD
     IFSAGCVIAE LFTEGVPLFD LSQLLAYRNG HFFPEQVLNK IEDHSIRELV TQMIHREPDK
     RLEAEDYLKQ QRGNAFPEIF YTFLQPYMAQ FAKETFLSAD ERILVIRKDL GNIIHNLCGH
     DLPEKAEGEP KENGLVILVS VITSCLQTLK YCDSKLAALE LILHLAPRLS VEILLDRITP
     YLLHFSNDSV PRVRAEALRT LTKVLALVKE VPRNDINIYP EYILPGIAHL AQDDATIVRL
     AYAENIALLA ETALRFLELV QLKNLNMEND PNNEEIDEVT HPNGNYDTEL QALHEMVQQK
     VVTLLSDPEN IVKQTLMENG ITRLCVFFGR QKANDVLLSH MITFLNDKND WHLRGAFFDS
     IVGVAAYVGW QSSSILKPLL QQGLSDAEEF VIVKALYALT CMCQLGLLQK PHVYEFASDI
     APFLCHPNLW IRYGAVGFIT VVARQISTAD VYCKLMPYLD PYITQPIIQI ERKLVLLSVL
     KEPVSRSIFD YALRSKDITS LFRHLHMRQK KRNGSLPDCP PPEDPAIAQL LKKLLSQGMT
     EEEEDKLLAL KDFMMKSNKA KANIVDQSHL HDSSQKGVID LAALGITGRQ VDLVKTKQEP
     DDKRARKHVK QDSNVNEEWK SMFGSLDPPN MPQALPKGSD QEVIQTGKPP RSESSAGICV
     PLSTSSQVPE VTTVQNKKPV IPVLSSTILP STYQIRITTC KTELQQLIQQ KREQCNAERI
     AKQMMENAEW ESKPPPPGWR PKGLLVAHLH EHKSAVNRIR VSDEHSLFAT CSNDGTVKIW
     NSQKMEGKTT TTRSILTYSR IGGRVKTLTF CQGSHYLAIA SDNGAVQLLG IEASKLPKSP
     KIHPLQSRIL DQKEDGCVVD MHHFNSGAQS VLAYATVNGS LVGWDLRSSS NAWTLKHDLK
     SGLITSFAVD IHQCWLCIGT SSGTMACWDM RFQLPISSHC HPSRARIRRL SMHPLYQSWV
     IAAVQGNNEV SMWDMETGDR RFTLWASSAP PLSELQPSPH SVHGIYCSPA DGNPILLTAG
     SDMKIRFWDL AYPERSYVVA GSTSSPSVSY YRKIIEGTEV VQEIQNKQKV GPSDDTPRRG
     PESLPVGHHD IITDVATFQT TQGFIVTASR DGIVKVWK
//
